Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3Recurrence 2Wilms Tumor 1Ovarian Neoplasms 1Neoplasm Metastasis 1Fallopian Tube Neoplasms 1Death 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1

Interventions

Vincristine 16Cyclophosphamide 16Filgrastim 13Etoposide 12Doxorubicin 12Radiotherapy 11Carboplatin 10X-Rays 9Dactinomycin 9Specimen Handling 8Phantoms, Imaging 8Magnetic Resonance Spectroscopy 8Granulocyte Colony-Stimulating Factor 8Temozolomide 6Melphalan 6Ifosfamide 6Topotecan 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Irinotecan 5Busulfan 5Biopsy 5sargramostim 4Stem Cell Transplantation 4Thiotepa 3Radiation 3Nivolumab 3Mesna 3Itraconazole 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Wilms Tumor × Genes, p53 × Clear all
NCT04758455 2021-02-17

The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence

Mansoura University

Phase NA Unknown
75 enrolled
Genitourinary

Death, Wilms Tumor, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡